Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Transplant Immunology
- Vol. 14 (3-4) , 207-219
- https://doi.org/10.1016/j.trim.2005.03.009
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phaseBlood, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunitiesTransplantation and Cellular Therapy, 2001
- Mini-allografts: ongoing trials in humansBone Marrow Transplantation, 2000
- Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous diseaseBone Marrow Transplantation, 1999
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantationThe Lancet, 1998
- Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experienceKlinische Padiatrie, 1998
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Aplastic Anemia: Pathogenesis and TreatmentOncology Research and Treatment, 1987
- Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated LymphocytesAnnual Review of Immunology, 1986